Form 4: Lemaitre Vascular Director Roberts Acquires Dividend Equivalent Rights
SEC Form 4
Director David B. Roberts acquired dividend equivalent rights related to restricted stock unit awards and performance share units of Lemaitre Vascular, Inc.
Summary
- On August 29, 2024, David B. Roberts, a director and President of Lemaitre Vascular, Inc., acquired dividend equivalent rights.
- These rights are associated with previously granted restricted stock unit (RSU) and performance share unit (PSU) awards.
- The acquisitions include 0.6646 rights related to a 2019 RSU award, 1.252 rights related to a 2020 RSU award, 2.3821 rights related to a 2021 RSU award, 3.6399 rights related to a 2022 RSU award, 3.6399 rights related to a 2022 PSU award, and 4.1477 rights related to a 2023 RSU award.
- Each dividend equivalent right is economically equivalent to one share of Lemaitre Vascular's common stock and vests proportionately with the associated award.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing the acquisition of dividend equivalent rights, which is neither particularly positive nor negative.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates the acquisition of dividend equivalent rights, which are a common feature of equity compensation plans.
Stakeholder Impact
- The acquisition of dividend equivalent rights has a minimal direct impact on stakeholders.
- It reflects ongoing compensation practices for company executives.
Key Dates
| Date | Description |
|---|---|
| 12/20/2019 | Date of restricted stock unit award related to dividend equivalent rights. |
| 12/02/2020 | Date of restricted stock unit award related to dividend equivalent rights. |
| 12/11/2021 | Date of restricted stock unit award related to dividend equivalent rights. |
| 12/12/2022 | Date of restricted stock unit and performance share unit awards related to dividend equivalent rights. |
| 12/08/2023 | Date of restricted stock unit award related to dividend equivalent rights. |
| 08/29/2024 | Date of transaction: Acquisition of dividend equivalent rights. |
| 09/03/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.